FDA Flags Shortage of Medication Used to Treat Breathing Conditions FDA Flags Shortage of Medication Used to Treat Breathing Conditions

The US health regulator said on Wednesday that it is working to address a shortage of a particular form of albuterol, a medication used to treat breathing conditions, as its sole manufacturer Akorn has stopped production.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news